Marksans Pharma informs about press release

21 Aug 2024 Evaluate
Marksans Pharma has informed that it enclosed press release titled ‘Marksans Pharma Limited’s wholly owned subsidiary Relonchem Limited receives Marketing Authorization for its products’.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

173.30 0.35 (0.20%)
12-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1825.00
Dr. Reddys Lab 1318.75
Cipla 1325.25
Zydus Lifesciences 916.55
Lupin 2356.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×